Article

New dry eye emulsion introduced

A new therapy (Retaine MGD, OCuSOFT) is available for those who have dry eye syndrome and meibomian gland dysfunction.

Rosenberg, TX-A new therapy (Retaine MGD, OCuSOFT) is available for those who have dry eye syndrome and meibomian gland dysfunction.

The company says it’s the only preservative-free oil-in-water emulsion that moisturizes, lubricates, and protects moderately to severely dry eyes. Using a proprietary cationic process (Novasorb) that binds positively charged ions to the negatively charged ocular surface, the product is designed to prolong corneal contact time to enhance comfort. The hypotonicity of the emulsion adds moisture by lowering the salt concentration of tears, and the lipid component is designed to lubricate and protect the surface of the eye.

“OCuSOFT is extremely excited to offer such a unique solution for dry eye therapy,” said Cynthia L. Barratt, president and chief executive officer of OCuSOFT. “We believe [the emulsion] will become the standard of care for those patients suffering from meibomian gland dysfunction as well as moderate to severe dry eyes.”

The emulsion is packaged in 30 single-dose vials. The company plans to expand the line to include additional artificial tear products.

Special discount pricing is available to physicians dispensing the emulsion from their offices, and patients also may order it directly online at www.retainebrand.com.

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.